Comprehensive, comparative evaluation of 25 automated SARS-CoV-2 serology assays
ABSTRACT The onset of the COVID-19 pandemic resulted in hundreds of in vitro devices coming to market, facilitated by regulatory authorities allowing “Emergency Use,” without a prior comprehensive evaluation of performance. The World Health Organization released Target Product Profiles specifying ac...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2024-01-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03228-23 |